Publication:
PSMA expression on neovasculature of solid tumors

Thumbnail Image
Files
Van-de-Wiele-35-919-927-2020.pdf(537.32 KB)
Date
2020
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Wiele, Christophe Van de ; Sathekge, Mike ; Spiegeleer, Bart de ; Jonghe, Pieter Jan De ; Debruyne, Philip R. ; Borms, Marleen ; Beels, Laurence ; Maes, Alex
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-215
item.page.type
info:eu-repo/semantics/article
Description
Abstract
The use of prostate specific membrane antigen (PSMA) binding agents, labelled with diagnostic and therapeutic radio-isotopes is opening the potential for a new era of personalized management of prostate carcinoma. A wide variety of immuno- histochemistry studies have shown PSMA also to be upregulated on the endothelial cells of the neovasculature of a wide variety of other solid tumors where it may facilitate endothelial cell sprouting and invasion through its regulation of lytic proteases that have the ability to cleave the extracellular matrix. Similar to the introduction of PSMA-targeting theranostics in prostate carcinoma, overexpression of PSMA on newly formed tumor vessels may serve as a target for imaging and subsequent treatment of cancer through the use of agents that are capable of blocking PSMA in its function or through PSMA-mediated delivery of chemotherapeutics or radiation agents. In this review, the available data on PSMA expression on tumor neovasculature in human solid tumors assessed by using immunohistochemistry are discussed
publication.page.subject
PSMA , Neovasculature , Solid tumors
Citation
Histology and Histopathology Vol. 35, nº9 (2020)
URI
http://hdl.handle.net/10201/126203
item.page.embargo
Collections
Histology and histopathology Vol.35, nº9 (2020)
Ir a Estadísticas